Clinical Biochemistry Practice Questions

Q: Which biochemical marker would be most elevated in a patient with osteoporosis?

N-terminal telopeptide (NTX). ***N-terminal telopeptide (NTX)*** - **NTX** is a marker of **bone resorption**, reflecting the breakdown of type I collagen during bone turnover. - In osteoporosis, bone resorption exceeds bone formation, making **resorption markers like NTX the most elevated** biochemical markers. - NTX is widely used clinically to assess bone turnover and monitor treatment response in osteoporosis. - Elevated urinary or serum NTX indicates increased osteoclast activity and accelerated bone loss. *C-terminal telopeptide (CTX)* - **CTX** is also a bone resorption marker that measures collagen breakdown products. - Like NTX, it is elevated in osteoporosis, and both are considered equally valid markers of bone resorption. - CTX is often measured in serum and is also used to monitor osteoporosis treatment. - While CTX would also be significantly elevated, NTX and CTX are comparable markers of the same process. *Alkaline phosphatase* - **Alkaline phosphatase (ALP)**, particularly the bone-specific isoenzyme, reflects **osteoblast activity** and bone formation. - In **primary osteoporosis**, ALP levels are typically **normal or only mildly elevated**, as the problem is predominantly increased resorption. - Marked elevation of ALP suggests other bone disorders like **Paget's disease, osteomalacia, or active fracture healing**. *Parathyroid hormone (PTH)* - **PTH** is a regulatory hormone, not a bone turnover marker. - In primary osteoporosis, PTH levels are typically **normal**. - Elevated PTH suggests **secondary causes** such as primary hyperparathyroidism or vitamin D deficiency leading to secondary hyperparathyroidism. - PTH elevation would be a cause of osteoporosis rather than a marker of the disease itself.

Q: Which biochemical marker is most indicative of a myocardial infarction?

Cardiac troponin I. ***Cardiac troponin I*** - **Cardiac troponin I** is highly specific to cardiac muscle and is released into the bloodstream following myocardial cell injury. - Its presence at elevated levels is the **gold standard** for diagnosing a myocardial infarction and usually remains elevated for several days. *Alanine transaminase* - **Alanine transaminase (ALT)** is primarily an enzyme found in the liver and is a marker for **hepatic damage**. - While mild elevations can be seen in various conditions, it is not specific for cardiac injury. *Aspartate transaminase* - **Aspartate transaminase (AST)** is found in various tissues including the liver, heart, skeletal muscle, and kidneys. - Although it can be elevated after a MI, it is **not specific to cardiac injury** and can be elevated in liver disease, muscle damage, and hemolysis. *Alkaline phosphatase* - **Alkaline phosphatase (ALP)** is an enzyme primarily found in bone, liver, intestines, and placenta. - Elevated levels are typically associated with **liver disease (especially cholestatic)** or **bone disorders** and have no diagnostic significance for myocardial infarction.

Q: Which of the following biochemical tests was traditionally used to diagnose Dubin Johnson syndrome?

Bromsulphalein test (BSP). ***Bromsulphalein test (BSP)*** - The **Bromsulphalein (BSP) test** was traditionally used because patients with Dubin-Johnson syndrome exhibit a characteristic **secondary rise in plasma BSP** concentration, indicating impaired hepatic excretion of the dye. - This peculiar excretion pattern, with **re-release of conjugated BSP** from hepatocytes due to a defect in canalicular transport, was a diagnostic hallmark. *Serum transaminases* - **Serum transaminase levels** (ALT, AST) are typically normal in Dubin-Johnson syndrome, as it is a benign disorder of bilirubin transport, not hepatocyte injury. - Elevated transaminases would suggest **hepatocellular damage**, which is not the primary pathology in Dubin-Johnson. *Hippurate test* - The **hippurate test** measures hepatic conjugation and excretion capacity, primarily for benzoic acid, and is not specifically indicative of Dubin-Johnson syndrome. - This test is more often associated with overall **hepatic metabolic capacity** rather than specific transporter defects. *Gamma glutamyl transferase level* - **Gamma-glutamyl transferase (GGT)** levels are usually normal in Dubin-Johnson syndrome, as it is not a cholestatic or hepatobiliary obstructive disorder. - Elevated GGT typically points towards **biliary pathologies** or alcohol-related liver disease.

Q: What mediates oncogenic osteomalacia?

Phosphatonin. ***Phosphatonin*** - **Phosphatonin** is a general term for a group of phosphaturic hormones, with **FGF23 (fibroblast growth factor 23)** being the primary mediator of oncogenic osteomalacia. - Tumors produce excessive amounts of **FGF23**, leading to renal phosphate wasting and impaired vitamin D activation, which causes **osteomalacia**. *Calcitonin* - **Calcitonin** is a hormone produced by the parafollicular cells of the thyroid gland, primarily involved in **decreasing blood calcium levels** by inhibiting osteoclast activity and reducing renal calcium reabsorption. - It does not play a direct role in the pathogenesis of **oncogenic osteomalacia**, which is characterized by phosphate dysregulation. *Interleukin 2* - **Interleukin 2 (IL-2)** is a cytokine primarily involved in the **immune system**, promoting the growth and differentiation of T cells. - It is not directly implicated in **phosphate metabolism** or the development of oncogenic osteomalacia. *Interleukin 6* - **Interleukin 6 (IL-6)** is a cytokine with diverse roles in inflammation, immune response, and hematopoiesis. - While IL-6 can influence bone metabolism in other contexts (e.g., chronic inflammation), it is **not the direct mediator** of phosphate wasting seen in oncogenic osteomalacia.

Q: What does Gerhardt's test help to identify?

Ketone bodies. ***Ketone bodies*** - Gerhardt's test (also known as ferric chloride test) specifically identifies the presence of **acetoacetate**, one of the three major ketone bodies, in urine. - A positive result is indicated by a **burgundy or reddish-brown color** when ferric chloride is added to a urine sample containing acetoacetate. *Reducing sugars* - Detecting reducing sugars, such as **glucose**, is typically done using **Benedict's test** or Clinitest tablets. - These tests rely on the reduction of copper sulfate to cuprous oxide, not a color change with ferric chloride. *Proteins* - The presence of protein in urine is usually detected by **sulfosalicylic acid test** or **reagent strips** based on the protein error of indicators. - Gerhardt's test does not react with proteins. *Blood* - Blood in urine (hematuria) is identified using **reagent strips** which detect the peroxidase activity of hemoglobin, or through microscopic examination for red blood cells. - This is unrelated to Gerhardt's test.

Q: Bilirubin in serum can be measured by

Van den Bergh reaction. ***Van den Bergh reaction*** - The **Van den Bergh reaction** is a common laboratory method used to quantify **bilirubin** in serum. - This method differentiates between direct (conjugated) and indirect (unconjugated) bilirubin using a **diazotized sulfanilic acid** reagent. *Ehrlich's Reaction* - **Ehrlich's reaction** is primarily used to detect **urobilinogen** in urine, not bilirubin in serum. - It involves the reaction of urobilinogen with **Ehrlich's reagent** (p-dimethylaminobenzaldehyde) to form a red color. *Schlesinger's Reaction* - **Schlesinger's reaction** is a test for the presence of **urobilin** in urine. - It uses a zinc salt, which reacts with urobilin to produce a characteristic **green fluorescence**. *Fouchet's Reaction* - **Fouchet's reagent** is used in urine analysis to detect the presence of **bilirubin** in a semi-quantitative manner, often indicating liver disease or biliary obstruction. - This reaction typically employs trichloroacetic acid and ferric chloride to produce a characteristic color change.

Q: Which of the following is a positive acute phase protein that enhances the acute phase response?

Fibrinogen. ***Fibrinogen*** - **Fibrinogen** is a key **positive acute phase protein** whose concentration increases significantly during inflammation - Its elevation contributes to the acute phase response by promoting **blood clotting** and influencing **erythrocyte sedimentation rate (ESR)** - Along with C-reactive protein (CRP), haptoglobin, and serum amyloid A, fibrinogen is among the major positive acute phase reactants *Transferrin* - **Transferrin** is a **negative acute phase protein**, meaning its concentration decreases during inflammation - This reduction is part of the body's iron-sequestration strategy to limit iron availability for invading pathogens - The decrease in transferrin helps restrict bacterial growth by reducing available iron *Albumin* - **Albumin** is a prominent **negative acute phase protein**, with its concentration decreasing during acute inflammation due to redistribution and reduced synthesis - It plays a vital role in maintaining **oncotic pressure** and transporting various substances - Its decline reflects the severity of inflammation and is used as a marker of the acute phase response *Prealbumin* - **Prealbumin** (also known as transthyretin) is a **negative acute phase protein** and a sensitive marker of nutritional status - Its rapid decline during inflammation makes it a useful indicator, as its synthesis is quickly reduced - It has a short half-life (2-3 days), making it more sensitive to acute changes than albumin

Q: What is the estimated blood glucose level in mg/dL for a patient with an HbA1c of 8% based on the conversion formula?

200. ***200*** - The estimated average glucose (eAG) can be calculated from HbA1c using the formula: **eAG (mg/dL) = 28.7 × HbA1c (%) – 46.7**. - For an HbA1c of 8%, the calculation is: **28.7 × 8 – 46.7 = 229.6 – 46.7 = 182.9 mg/dL**, which is closest to 200 mg/dL among the given options. *120* - An eAG of 120-125 mg/dL would correspond to an **HbA1c between 5.8% and 6.0%**, which is below the given 8%. - This value typically reflects **well-controlled or pre-diabetic** blood glucose levels. *160* - An eAG of 160 mg/dL would correspond to an **HbA1c of approximately 7.0-7.2%**, which is lower than the given 8%. - This level is often the target for HbA1c in many **diabetic management guidelines**, but not for 8%. *240* - An eAG of 240 mg/dL would correspond to an **HbA1c of approximately 9.9%**, which is significantly higher than the given 8%. - This indicates **poorly controlled diabetes** and a much higher average blood glucose level.

Q: In which condition is the Albumin to Globulin (A:G) ratio maintained?

Nephritic syndrome. ***Nephritic syndrome*** - In nephritic syndrome, the **glomerular filtration is often preserved**, allowing for the maintenance of A:G ratio despite the presence of hematuria and proteinuria [1]. - The condition typically leads to a **moderate degree of proteinuria**, retaining a relatively normal serum albumin level [1]. *Multiple myeloma* - In multiple myeloma, there is often a **high level of paraproteins** leading to a significant drop in albumin, affecting the A:G ratio. - Patients frequently exhibit **renal impairment**, resulting in a disrupted A:G ratio due to increased urinary protein loss. *Protein losing enteropathy* - This condition causes **loss of proteins** like albumin through the gastrointestinal tract, leading to **hypoalbuminemia** and altered A:G ratio. - It is characterized by **diarrhea** and fluid accumulation, further impacting the protein status in circulation. *Cirrhosis* - Cirrhosis leads to **decreased albumin synthesis**, resulting in a low serum albumin and an altered A:G ratio. - The condition is associated with **portal hypertension** and ascites, complicating the biochemical status.

Q: Cystatin C levels are used for

Estimating GFR. ***Estimating GFR*** - **Cystatin C** is a **proteinase inhibitor** produced by all nucleated cells at a constant rate, and its level in the blood is inversely related to the **glomerular filtration rate (GFR)**. - Unlike **creatinine**, Cystatin C levels are less affected by **muscle mass, diet, or inflammation**, making it a more reliable marker for early and subtle changes in GFR, especially in certain populations. *Detecting UTI* - **Urinary tract infections (UTIs)** are primarily detected through **urinalysis** (presence of **leukocytes, nitrites**, and **bacteria**) and **urine culture**. - **Cystatin C** is a serum marker for renal function and has no direct role in detecting the presence of bacterial infection in the urinary tract. *Estimating difference between CRF and ARF* - Differentiating between **chronic renal failure (CRF)** and **acute renal failure (ARF)** typically involves assessing the **chronicity of symptoms**, trend in **creatinine levels**, and **kidney size** and **echogenicity** on ultrasound. - While Cystatin C can reflect current GFR, it doesn't inherently provide discriminatory power between acute and chronic processes without serial measurements or additional clinical context. *Screening for Renal Ca* - **Renal cell carcinoma (RCC)** screening is primarily done using **imaging techniques** like **ultrasonography, CT, or MRI**, especially in individuals with risk factors or symptoms like **hematuria**. - **Cystatin C** is a marker of kidney function and does not serve as a tumor marker for renal cancer.

Question 1

Which biochemical marker would be most elevated in a patient with osteoporosis?

Accepted Answer

N-terminal telopeptide (NTX)

Answer

Alkaline phosphatase

Answer

C-terminal telopeptide (CTX)

Answer

Parathyroid hormone (PTH)

Question 2

Which biochemical marker is most indicative of a myocardial infarction?

Accepted Answer

Cardiac troponin I

Answer

Alanine transaminase

Answer

Aspartate transaminase

Answer

Alkaline phosphatase

Question 3

Which of the following biochemical tests was traditionally used to diagnose Dubin Johnson syndrome?

Accepted Answer

Bromsulphalein test (BSP)

Answer

Serum transaminases

Answer

Hippurate test

Answer

Gamma glutamyl transferase level

Question 4

What mediates oncogenic osteomalacia?

Accepted Answer

Phosphatonin

Answer

Calcitonin

Answer

Interleukin 2

Answer

Interleukin 6

Question 5

What does Gerhardt's test help to identify?

Accepted Answer

Ketone bodies

Answer

Reducing sugars

Answer

Proteins

Answer

Blood

Question 6

Bilirubin in serum can be measured by

Accepted Answer

Van den Bergh reaction

Answer

Ehrlich’s Reaction

Answer

Schlesinger’s Reaction

Answer

Fouchet's Reaction

Question 7

Which of the following is a positive acute phase protein that enhances the acute phase response?

Accepted Answer

Fibrinogen

Answer

Transferrin

Answer

Albumin

Answer

Prealbumin

Question 8

What is the estimated blood glucose level in mg/dL for a patient with an HbA1c of 8% based on the conversion formula?

Accepted Answer

200

Answer

120

Answer

160

Answer

240

Question 9

In which condition is the Albumin to Globulin (A:G) ratio maintained?

Accepted Answer

Nephritic syndrome

Answer

Cirrhosis

Answer

Protein losing enteropathy

Answer

Multiple myeloma

Question 10

Cystatin C levels are used for

Accepted Answer

Estimating GFR

Answer

Detecting UTI

Answer

Screening for Renal Ca

Answer

Estimating difference between CRF and ARF

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?